These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 9102559)

  • 21. Economic burden of illness imposed by severe sepsis in Austria.
    Schmid A; Schneider H; Adlof A; Smolle KH; Edelmann G; Sporn P; Frass M; Sumann G; Koller W; Schobersberger W
    Wien Klin Wochenschr; 2002 Aug; 114(15-16):697-701. PubMed ID: 12602114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Occupational data cards as a source of information for health prevention purposes].
    Bugajska J
    Med Pr; 2000; 51(6):551-61. PubMed ID: 11288683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evolution of industrial toxicology toward vanishing doses and the human genome].
    Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
    Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anesthesia, department of anesthesiology and anesthesiology--why has anesthesiology not been accepted socially in Japan?].
    Matsuki A
    Masui; 2000 Feb; 49(2):195-200. PubMed ID: 10707528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epilepsy, eponyms and patron saints (history of Western civilization)].
    Janković SM; Sokić DV; Lević ZM; Susić V; Stojsavljević N; Drulović J
    Srp Arh Celok Lek; 1996; 124(5-6):162-5. PubMed ID: 9102840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The contribution of social medicine to vaccination in Austria].
    Kunze M
    Wien Med Wochenschr; 1998; 148(8-9):191-7. PubMed ID: 9677675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Na+ and Mg2+ on the structures of supercoiled DNAs: comparison of simulations with experiments.
    Gebe JA; Delrow JJ; Heath PJ; Fujimoto BS; Stewart DW; Schurr JM
    J Mol Biol; 1996 Sep; 262(2):105-28. PubMed ID: 8831783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A bivariate parametric model for survival and intermediate event times.
    Epstein LD; Muñoz A
    Stat Med; 1996 Jun; 15(11):1171-85. PubMed ID: 8804146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fitness for work: the SIMLII Health Surveillance Guidelines.
    Soleo L; Romano C; Apostoli P
    Med Lav; 2006; 97(3):491-500. PubMed ID: 17009686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Human ecology and interdisciplinary cooperation for primary prevention of environmental risk factors for public health].
    Dobrowolski JW
    Przegl Lek; 2007; 64 Suppl 4():35-41. PubMed ID: 18540323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of the 'critical effect' and 'critical concentration' concept to human risk assessment for cadmium.
    Nordberg GF
    IARC Sci Publ; 1992; (118):3-14. PubMed ID: 1303955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Health inequalities among occupations: epidemiologic hints for labour and social protection policies].
    Costa G
    Med Lav; 2005; 96 Suppl():s7-27. PubMed ID: 15871615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk assessment and management of occupational exposure to pesticides in agriculture.
    Maroni M; Fanetti AC; Metruccio F
    Med Lav; 2006; 97(2):430-7. PubMed ID: 17017381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of fullerene toxicity and exposure--appraisal of a human health risk assessment, based on open literature.
    Aschberger K; Johnston HJ; Stone V; Aitken RJ; Tran CL; Hankin SM; Peters SA; Christensen FM
    Regul Toxicol Pharmacol; 2010 Dec; 58(3):455-73. PubMed ID: 20800639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.